In 2003 Dian Liu was appointed CEO of Luye Pharma Group Ltd. (HKG:2186). This analysis aims first to contrast CEO compensation with other companies that have similar market capitalization. Then we'll ...

Add Yahoo as a preferred source to see more of our stories on Google. (Reuters) - Hong Kong-based private equity firm Templewater is acquiring Luye Medical Group's oncology and cardiology businesses ...

Luye Pharma has entered a space targeted by Johnson & Johnson and Teva, securing FDA approval for its extended-release injectable formulation of risperidone in schizophrenia and bipolar I disorder.

Dian Liu has been the CEO of Luye Pharma Group Ltd. (HKG:2186) since 2003. This report will, first, examine the CEO compensation levels in comparison to CEO compensation at companies of similar size.

Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: A man walks past a sign at an AstraZeneca site in Macclesfield, central England May 19, 2014. REUTERS/Phil Noble//File ...

Luye Pharma Group (HK:2186) has released an update. Luye Pharma Group has announced a revised closing date for its issuance of $100 million convertible bonds, now set for October 30, 2024. The change ...

PRINCETON, N.J., April 6, 2025 /PRNewswire/ -- Luye Pharma Group today announced that ERZOFRI® (paliperidone palmitate) extended-release injectable suspension is now available for commercial sale in ...

SINGAPORE - Singapore-based Luye Medical Group has completed a majority equity investment in Novena Heart Centre (NHC), it said on Tuesday (April 10). The deal - for an undisclosed amount - is the ...

(RTTNews) - The board of Luye Pharma Group Ltd. (2186.HK) announced that certain subsidiaries of the Group have entered into an agreement with Jiangsu Nhwa Hexin Pharmaceutical Marketing Co., a ...

Chinese pharmaceutical maker Luye Pharmaceutical, led by one of the wealthiest entrepreneurs in China’s Shandong Province, is near the completion of a move of its listing from the Singapore Stock ...

Luye Medical Group Co announced on Monday that it has agreed to buy private equity-owned Australian hospital operator Healthe Care Pty Ltd in the Chinese company's first foray into the hospital sector ...

(Reuters) - Hong Kong-based private equity firm Templewater is acquiring Luye Medical Group's oncology and cardiology businesses in Singapore, the company said on Tuesday. Financial terms of the deal ...